Clinical Trial

Romiplostim N01 for Platelet Recovery in Adult Hematologic Malignancies Patients Undergoing UCBT

Name: Romiplostim N01 for Platelet Recovery in Adult Hematologic Malignancies Patients Undergoing UCBT — clinical trial record (NCT06693791)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

To evaluate the efficacy and safety of Romiplostim N01 for platelet recovery after umbilical cord blood transplantation (UCBT) in patients with hematological malignancies.

Trial Details

NCT Number	NCT06693791
Lead Sponsor	Anhui Provincial Hospital
Conditions	Platelet Recovery After Umbilical Cord Blood Transplantation
Enrollment	34 participants
Start Date	2024-12-01
Primary Completion	2026-11-01 (estimated)
Study Completion	2026-12-01 (estimated)
Updated on ClinicalTrials.gov	2024-11-18